A phase I/II study of continuous intra-arterial chemotherapy using an implantable reservoir for the treatment of liver metastases from breast cancer: A Japan Japan Clinical Oncology Group (JCOG) study 9113

Japanese Journal of Clinical Oncology

Volumn 29, Issue 1, 1999, Pages 23-27

  Ikeda, Tadashi ^a   Adachi, Isamu ^b   Takashima, Shigemitsu ^c   Ogita, Masami ^d   Aoyama, Hideaki ^e   Sano, Muneaki ^f   Ando, Jiro ^g   Tabei, Toshio ^h   Tominaga, Takeshi ⁱ   Enomoto, Kohji ^a   Kanda, Kazuhiro ^j   Fukutomi, Takashi ^b   Shimoyama, Masanori ^e  

^a KEIO UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

^d HOKKAIDO CANCER CENTER   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^f NIIGATA CANCER CENTER HOSPITAL   (Japan)

^g TOCHIGI CANCER CENTER   (Japan)

^h SAITAMA CANCER CENTER   (Japan)

ⁱ TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^j HAMAMATSU MEDICAL CENTER   (Japan)

more..

Author keywords

Breast cancer; Hepatic metastasis; Intra arterial chemotherapy; Phase I II study

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; FLUOROURACIL;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DRUG ADMINISTRATION; FEMALE; HEPATIC ARTERY; HUMAN; INFUSION PUMP; INTRAARTERIAL DRUG ADMINISTRATION; LEUKOPENIA; LIVER TUMOR; METASTASIS; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; SURVIVAL; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HEPATIC ARTERY; HUMANS; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, INTRA-ARTERIAL; LEUKOPENIA; LIVER NEOPLASMS; MIDDLE AGED; SURVIVAL ANALYSIS; THROMBOCYTOPENIA;

EID: 0032617480     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/29.1.23     Document Type: Article

References (17)

1. Shimozuma K, Tominaga T, Hayashi K, Kosaki G. Characteristics and treatment for liver metastasis from breast cancer. Nippon Gan Chiryo Gakkai Shi 1991;26:1087-94 (in Japanese).
2. Nakamura T, Sakamoto G, Kitagawa T, Kasuga T, Sugano H. Metastasis in breast carcinoma; analysis of 135 autopsied cases. Gan No Rinsho 1983;29:1717-20 (in Japanese).
3. Tominaga T. Recent treatment for hepatic metastasis from breast cancer. Geka Shinryo 1990;32:830-5 (in Japanese).
4. Kemeny N. The systemic chemotherapy of hepatic metastasis. Semin Oncol 1983;10:148-58.
5. Goldberg JA, Kerr DJ, Wilmott N, McKillop JH, McArdle CS. Regional chemotherapy for colorectal liver metastasis: a phase II evaluation of targeted hepatic arterial 5-fluorouracil for colorectal liver metastasis. Br J Surg 1990;77:1238-40.
6. Meta-Analysis Group in Cancer. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 1996;88:252-8.
7. Ensminger WD, Rosowsky A, Raso V, Levin DC, Glode M, Come S, et al. A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2-deoxyuridine and 5-fluorouracil. Cancer Res 1978;38:3784-92.
8. Arai Y, Kido C, Endo T, Aoki T. Preliminary results of a phase II study of 5-FU, adriamycin and mitomycin C (FAM) in combined hepatic infusion in patients with non-resectable metastatic liver cancer. Gan To Kagaku Ryoho 1987;14:2327-33 (in Japanese).
9. Schneebaum S, Walker MJ, Young D, Farrar WB, Minton JP. The regional treatment of liver metastases from breast cancer. J Surg Oncol 1994;55:26-31.
10. Goldberg JA, Kerr DJ, Stewart I, McArdle CS. A comparison of regional and systemic chemotherapy for hepatic metastasis. Eur J Surg Oncol 1990;16:464-7.
11. Venook AP, Warren RS. Regional chemotherapy approaches for primary and metastatic liver tumors. Surg Oncol Clin N Am 1996;5:411-27.
12. Lokich JJ, Ahlgren JD, Gullo JJ, Philips JA, Fryer JG. A prospective randomized comparison of continuous infusion of fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program study. J Clin Oncol 1989;7:425-32.
13. Spicer DV, Ardalan B, Daniels JR, Silberman H, Johnson K. Reevaluation of the maximum tolerated dose of continuous venous infusion of 5-fluorouracil with pharmacokinetics. Cancer Res 1988;48:459-61.
14. Takatsuka Y, Imamotoh H, Tsuchiyama M, Numata N, Kawahara T. Intra-arterial infusion chemotherapy with adriamycin for the treatment of locally advanced breast cancer - Studies of serum and tissue concentration of adriamycin. Gan To Kagaku Ryoho 1982;9:880-7 (in Japanese).
15. Fujiwara K. Experimental and clinical studies on optimal administration schedule of 4-o-tetrahydropyranyl adriamycin for breast cancer. Keio Igaku 1988;65:147-62 (in Japanese).
16. Lorenz M, Wiesner J, Staib-Sebler E, Encke A. Regional therapy breast cancer liver metastases. Zentralbl Chir 1995;120:786-90.
17. Zinser JW, Hortobagyi GN, Buzdar AU, Smith TL, Fraschini G. Clinical course of breast cancer patients with liver metastases. J Clin Oncol 1987;5:773-782.